Industry Conference

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Transcarent's WayFinding 2.0 moves beyond chat, using 'agentic AI' to schedule appointments, create health plans, and actively manage your care.

A new validation milestone between LitePoint and Qualcomm shows Wi-Fi 8 is approaching, promising ultra-reliable networks for AI, AR, and mission-critical IoT.

Amid rising grid complexity and cyber threats, Haivision's real-time video solutions aim to give utility operators unprecedented situational awareness.

Winning Data Platform of the Year, Authenticom’s DXM connects live operations with customer sentiment, aiming to fix problems before they happen.

With a major new facility planned and a dynamic market, all eyes are on Clean Harbors as it prepares to address investors at two key January events.

Bio-Rad's leadership will meet investors at the J.P. Morgan conference, facing questions on strategy and growth in a competitive, tech-driven market.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

From your living room to your car, Dolby's latest CES announcements reveal a strategy to embed immersive entertainment into every aspect of your life.

With its lead muscular dystrophy drug in late-stage trials, Edgewise Therapeutics heads to the JPM conference with high stakes for its pipeline and stock.

A new antibody-drug conjugate, DEM301, shows preclinical promise by targeting a unique protein to directly kill tumors and unleash the immune system.

Legal tech leader Litera sees 10x user growth after offering its advanced AI at no extra cost, a bold move challenging competitor pricing and a new standard.

Early trial data for IKS014 reveals a high clinical benefit rate in pre-treated oesophageal cancer, offering a new beacon of hope for a hard-to-treat disease.

THX unveils Spatial Audio+ at CES 2026, bringing AI head tracking and 7.1.4 surround sound to headphones and laptops for unparalleled gaming and cinema.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

At CES 2026, a new platform combines Dolby Atmos FlexConnect and UWB tech, promising to make high-end surround sound easier than ever before.

South Korea's Curogen secures major national funding and targets global partners at the JP Morgan conference, advancing novel therapies for IBD and HS.

With a key drug decision looming and a refocused strategy, Rocket Pharmaceuticals faces a critical audience at the J.P. Morgan Healthcare Conference.

With its blockbuster drug's patent cliff looming, Merck's leadership faces high stakes at the JPM conference to unveil its strategy for future growth.

Following a stellar Black Friday, Energizer is expanding its retail footprint and unveiling next-gen chargers at CES, challenging tech accessory giants.